Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4597372013 | Belumosudil mesilate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4597373015 | Belumosudil mesilate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4597374014 | Belumosudil mesylate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5270811000052114 | belumosudilmesilat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belumosudil mesilate | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Belumosudil mesilate | Is a | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some | ||
| Belumosudil mesilate | Has disposition (attribute) | Rho-associated protein kinase inhibitor | true | Inferred relationship | Some | ||
| Belumosudil mesilate | Is modification of (attribute) | Belumosudil (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Belumosudil mesilate | Inferred relationship | Some | 1 |
Reference Sets
FHIR